Keystone Symposia

Humanities/Social Sciences Building of Academia Sinica Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

This meeting took place in 2020


Here are the related meetings in 2020:
Microbiome: Therapeutic Implications (T1)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

MEETING CANCELLED: Inflammation, Microbiota and Cancer (E3)


Organizer(s) Giorgio Trinchieri, Jenny P.Y. Ting, Hsing-Jien Kung and Jennifer A. Wargo
May 17—21, 2020
Humanities/Social Sciences Building of Academia Sinica • Taipei, Taiwan
Discounted Abstract Deadline: Jan 16, 2020
Abstract Deadline: Feb 18, 2020
Scholarship Deadline: Jan 16, 2020
Discounted Registration Deadline: Mar 17, 2020

Developed in collaboration with Academia Sinica
Global Advisory Council Members: Edmond Shie-Liang Hsieh, Fu-Tong Liu

Sponsored by Cell Research

Summary of Meeting:
The concept of inflammation being linked to tumor promoting and even initiating a tumor microenvironment has evolved to include a complex network of interactions: innate and acquired immune response to the tumor; metabolism in tumor and immune cells; local and systemic effects of the microbiota on tumor predisposition, promotion, response to chemotherapy, radiotherapy, and immune therapy; and finally cancer co-morbidities and therapeutic side effects. The metabolic tumor environment affects innate and immune cell metabolism and activity thus modulating tumor progression and the response to therapy, particularly immunotherapy, but also chemotherapy and radiotherapy. Innate signaling also affects the tumor microenvironment and a complex cross-talk involving innate receptors, trained immunity, and class I Major Histocompatibility Complex (MHC) regulates both inflammation and anti-tumor immunity. Also, rapid progress in experimental animals and more recently in cancer patients, is unraveling a complex interaction between the microbiota at epithelial surfaces and within the primary tumor and metastatic sites with response to therapy. This, in turn, is raising the hope to be able to predict patient response to different types of therapy and to target the microbiota for improving therapy response, decreasing toxicity and preventing co-morbidity. The new scientific areas that will be covered during this conference will bring together aspects of cancer biology and immunity that are often only discussed at separate specialized meetings. The presence of both basic and clinical investigators will expose the participants to these new concepts. This conference will also provide an opportunity to discuss and explore the clinical translation of this rapidly emerging new understanding of cancer immunobiology. Finally, as there is a growing interest regarding health differences that adversely affect ethnically distinct and/or disadvantaged populations, an afternoon workshop, entitled Effects of Race and Ethnicity on Microbiome: Impacts on Cancer Health Disparities will be incorporated into the conference program.

View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 24 hr (international) time


Program is being updated. Please check back soon for program details.